PyInvesting

Market research

002727.SHE Yixintang Pharmaceutical Group Co., Ltd

SHE CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
7B
P/E ratio
24.19
Analyst target
14.862
Dividend yield
3.4%
Beta
0.58

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Yixintang Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 15.3% below its 200 day moving average.

From a valuation standpoint, the stock is 78.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.

Yixintang Pharmaceutical Group Co., Ltd's total revenue rose by 21.3% to $3B since the same quarter in the previous year.

Its net income has increased by 55.1% to $186M since the same quarter in the previous year.

Finally, its free cash flow fell by 27.9% to $190M since the same quarter in the previous year.

Based on the above factors, Yixintang Pharmaceutical Group Co., Ltd gets an overall score of 3/5.